Market data in the Pharmaceutical Industry is arguably the most vital ingredient to plan and execute activities, where prices and advertising are heavily regulated. Data is not only important for strategic planning like new launches but also for tactical execution like growing market share or deciding on seasonal offers. Pharmaceutical business is heavily dependent on personal selling, which is an expensive complex tool. Data helps businesses monitor their sales performance, improve their sales force efficiency, create value for prescribers, dispensers and patients and achieve challenging targets.
AMS quarterly sales monitors cover the pharmaceutical markets in Jordan, Iraq, Syria, Sudan and most recently in Libya. These studies are designed to accurately reflect the quantitative sales of pharmaceutical products in the private sector. Each study undergoes rigorous internal audits to ensure that the highest standards of quality are maintained.
Complementing its quarterly sales monitors for the private market, AMS also delves into the realm of public procurement by issuing quarterly studies on institutional (tender) purchases. This comprehensive approach provides businesses with an unparalleled holistic view of both the private and the public data which provides an accurate analysis and presentation of all tenders awarded by and delivered to the Iraqi MOH (KIMADIA).
An Institutional study of the Governmental Procurement of Medicines will be available soon in Jordan.
With over 2 million prescriptions annually in Jordan, the Medical Prescription Monitor has proved to be an indispensable tool for pharmaceutical companies seeking to evaluate the effectiveness of their sales representatives and gain a competitive edge. This quarterly study goes beyond mere sales figures, offering a qualitative assessment of the promotional messages reaching physicians. By analyzing data from a representative sample of prescriptions, AMS provides in-depth insights into prescribing patterns, brand performance, and market dynamics. This study will be available soon in the Iraqi Market.
At AMS, we believe that understanding the unique research requirements of each client is key to the successful design and execution of a market research project. This customized approach is essential for maximizing the outcome of the conducted research and delivering actionable insights that align with your objectives.
Leveraging its team’s extensive experience in the pharmaceutical industry, a strong presence in several MENA countries, and an in-depth understanding of local culture and market dynamics, AMS is uniquely positioned to provide comprehensive consultations to pharmaceutical companies operating in the region. Whether your company seeks a market entry strategy, a distribution partner, or a comprehensive market analysis study, AMS is your ideal partner.
Being a leading provider of market data, research and consulting services to the pharmaceutical industry, AMS has laid the foundations to the expansion of its services to include patient support and affordability programs in Jordan and Iraq. This expansion marks a significant milestone in AMS’s commitment to providing comprehensive solutions that address the unique challenges faced by pharmaceutical companies operating in the MENA region.